MOLECULAR ENG ASS has a total of 26 patent applications. Its first patent ever was published in 1983. It filed its patents most often in Australia, Ireland and Israel. Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are PHILIPS ROXANE, BENZON PHARMA AS and ADVANCED GENETICS RES INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Ireland | 3 | |
#3 | Israel | 3 | |
#4 | New Zealand | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | South Africa | 3 | |
#7 | Canada | 2 | |
#8 | China | 2 | |
#9 | United States | 2 | |
#10 | Denmark | 1 | |
#11 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Machines | |
#4 | Environmental technology | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Unspecified technologies | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Ray Ranjit | 13 |
#2 | Compans Richard W | 13 |
#3 | Curtiss Roy Iii | 4 |
#4 | Gay Steffen | 2 |
#5 | Curtiss Roy | 2 |
#6 | Ranjit Ray | 2 |
#7 | Richard W Compans | 2 |
#8 | Curtis Roy Iii | 1 |
Publication | Filing date | Title |
---|---|---|
IE892830L | Fusion protein of paramyxovirus | |
NZ230425A | Production of paramyxovirus fusion (f) protein using recombinant baculovirus expression vector | |
IL86583D0 | Vaccine containing a derivative of a microbe and method for the production thereof | |
NZ224422A | Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid | |
US4628027A | Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins | |
CA1251729A | In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins |